Annual Cash & Cash Equivalents
$56.56 M
-$17.26 M-23.38%
December 31, 2023
Summary
- As of February 8, 2025, PDSB annual cash & cash equivalents is $56.56 million, with the most recent change of -$17.26 million (-23.38%) on December 31, 2023.
- During the last 3 years, PDSB annual cash & cash equivalents has risen by +$27.72 million (+96.12%).
- PDSB annual cash & cash equivalents is now -56.56% below its all-time high of $130.19 million, reached on December 31, 2015.
Performance
PDSB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$49.75 M
-$7.98 M-13.83%
September 30, 2024
Summary
- As of February 8, 2025, PDSB quarterly cash and cash equivalents is $49.75 million, with the most recent change of -$7.98 million (-13.83%) on September 30, 2024.
- Over the past year, PDSB quarterly cash and cash equivalents has dropped by -$6.81 million (-12.04%).
- PDSB quarterly cash and cash equivalents is now -61.79% below its all-time high of $130.19 million, reached on December 31, 2015.
Performance
PDSB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PDSB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.4% | -12.0% |
| 3 y3 years | +96.1% | -17.9% |
| 5 y5 years | +63.3% | -17.9% |
PDSB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.4% | at low | -32.6% | at low |
| 5 y | 5-year | -23.4% | +365.1% | -33.4% | +309.1% |
| alltime | all time | -56.6% | +619.8% | -61.8% | +309.1% |
PDS Biotechnology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $49.75 M(-13.8%) |
| Jun 2024 | - | $57.73 M(-13.4%) |
| Mar 2024 | - | $66.63 M(+17.8%) |
| Dec 2023 | $56.56 M(-23.4%) | $56.56 M(+4.3%) |
| Sep 2023 | - | $54.25 M(-10.5%) |
| Jun 2023 | - | $60.63 M(-7.0%) |
| Mar 2023 | - | $65.20 M(-11.7%) |
| Dec 2022 | $73.82 M(+13.1%) | $73.82 M(+3.0%) |
| Sep 2022 | - | $71.64 M(+35.2%) |
| Jun 2022 | - | $52.98 M(-10.0%) |
| Mar 2022 | - | $58.88 M(-9.8%) |
| Dec 2021 | $65.24 M(+126.2%) | $65.24 M(-6.5%) |
| Sep 2021 | - | $69.74 M(-6.7%) |
| Jun 2021 | - | $74.75 M(+198.6%) |
| Mar 2021 | - | $25.04 M(-13.2%) |
| Dec 2020 | $28.84 M(+137.1%) | $28.84 M(-13.8%) |
| Sep 2020 | - | $33.47 M(+97.6%) |
| Jun 2020 | - | $16.93 M(-19.5%) |
| Mar 2020 | - | $21.04 M(+73.0%) |
| Dec 2019 | $12.16 M | $12.16 M(-30.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $17.41 M(-19.9%) |
| Jun 2019 | - | $21.73 M(-18.3%) |
| Mar 2019 | - | $26.59 M(-23.2%) |
| Dec 2018 | $34.65 M(-60.7%) | $34.65 M(-5.9%) |
| Sep 2018 | - | $36.81 M(-19.9%) |
| Jun 2018 | - | $45.98 M(-38.7%) |
| Mar 2018 | - | $75.00 M(-14.8%) |
| Dec 2017 | $88.07 M(-17.2%) | $88.07 M(-9.5%) |
| Sep 2017 | - | $97.31 M(-10.5%) |
| Jun 2017 | - | $108.71 M(+13.7%) |
| Mar 2017 | - | $95.59 M(-10.2%) |
| Dec 2016 | $106.40 M(-18.3%) | $106.40 M(-5.7%) |
| Sep 2016 | - | $112.78 M(+1.6%) |
| Jun 2016 | - | $111.02 M(-7.4%) |
| Mar 2016 | - | $119.94 M(-7.9%) |
| Dec 2015 | $130.19 M(+848.3%) | $130.19 M(+146.2%) |
| Sep 2015 | - | $52.88 M(-9.6%) |
| Jun 2015 | - | $58.47 M(+325.9%) |
| Dec 2014 | $13.73 M(+74.7%) | $13.73 M |
| Dec 2013 | $7.86 M | - |
FAQ
- What is PDS Biotechnology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for PDS Biotechnology?
- What is PDS Biotechnology annual cash & cash equivalents year-on-year change?
- What is PDS Biotechnology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for PDS Biotechnology?
- What is PDS Biotechnology quarterly cash and cash equivalents year-on-year change?
What is PDS Biotechnology annual cash & cash equivalents?
The current annual cash & cash equivalents of PDSB is $56.56 M
What is the all time high annual cash & cash equivalents for PDS Biotechnology?
PDS Biotechnology all-time high annual cash & cash equivalents is $130.19 M
What is PDS Biotechnology annual cash & cash equivalents year-on-year change?
Over the past year, PDSB annual cash & cash equivalents has changed by -$17.26 M (-23.38%)
What is PDS Biotechnology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PDSB is $49.75 M
What is the all time high quarterly cash and cash equivalents for PDS Biotechnology?
PDS Biotechnology all-time high quarterly cash and cash equivalents is $130.19 M
What is PDS Biotechnology quarterly cash and cash equivalents year-on-year change?
Over the past year, PDSB quarterly cash and cash equivalents has changed by -$6.81 M (-12.04%)